dichloro-1,2-diaminocyclohexane platinum complex has been researched along with terfenadine in 1 studies
| Studies (dichloro-1,2-diaminocyclohexane platinum complex) | Trials (dichloro-1,2-diaminocyclohexane platinum complex) | Recent Studies (post-2010) (dichloro-1,2-diaminocyclohexane platinum complex) | Studies (terfenadine) | Trials (terfenadine) | Recent Studies (post-2010) (terfenadine) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 1,751 | 568 | 346 |
| Protein | Taxonomy | dichloro-1,2-diaminocyclohexane platinum complex (IC50) | terfenadine (IC50) |
|---|---|---|---|
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | 0.93 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 1.231 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 3.566 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 6.123 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 2 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.928 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.8167 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.32 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 2.9 | |
| D(2) dopamine receptor | Homo sapiens (human) | 6.167 | |
| Dipeptidyl peptidase 4 | Rattus norvegicus (Norway rat) | 0.35 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 2.34 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 3.748 | |
| D | Rattus norvegicus (Norway rat) | 0.1288 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.1288 | |
| Substance-K receptor | Homo sapiens (human) | 2.677 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 2.673 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.1288 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.1288 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 2.34 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.928 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.1288 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 2.34 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.255 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.231 | |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | 0.094 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 2.34 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.0115 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 2.34 | |
| D(3) dopamine receptor | Homo sapiens (human) | 1.503 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.048 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 2.34 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 1.306 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 8.1 | |
| C-C chemokine receptor type 5 | Homo sapiens (human) | 1.103 | |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | 0.93 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.255 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.2233 | |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | 0.93 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 1.125 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 0.971 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
1 other study(ies) available for dichloro-1,2-diaminocyclohexane platinum complex and terfenadine
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |